Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
NKGen Biotech Inc | NKGN | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
1.42 | 1.25 | 2.14 | 1.71 | 1.12 |
Noticias Recientes
Fecha | Hora | Fuente | Noticia |
---|---|---|---|
22/2/2024 | 15:01 | EDGAR2 | Form 8-K - Current report |
14/2/2024 | 19:19 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
14/2/2024 | 19:16 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
14/2/2024 | 19:14 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
14/2/2024 | 19:11 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
14/2/2024 | 12:05 | EDGAR2 | Form SC 13G - Statement of acquisition of beneficial.. |
22/1/2024 | 05:12 | EDGAR2 | Form 8-K - Current report |
08/1/2024 | 16:19 | EDGAR2 | Form 8-K - Current report |
28/12/2023 | 15:14 | EDGAR2 | Form 8-K - Current report |
27/12/2023 | 15:02 | EDGAR2 | Form 8-K - Current report |
27/12/2023 | 15:01 | EDGAR2 | Form 8-K - Current report |
19/12/2023 | 12:41 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |
14/11/2023 | 15:39 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
24/10/2023 | 09:56 | DJN | NKGen Biotech Shares Rise 8% After FDA Clears IND.. |
24/10/2023 | 07:05 | EDGAR2 | Form 8-K - Current report |